Merkliste 
 1 Ergebnisse 
 
1

BIRC5 (survivin): a pejorative prognostic marker in stage I..:

Hamy, A. S. ; Bieche, I. ; Lehmann-Che, J....
Breast Cancer Research and Treatment.  159 (2016)  3 - p. 499-511 , 2016